欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/1209/001
药品名称Cabazitaxel TEVA 10 mg/ml Concentrate for solution for infusion
活性成分
    • Cabazitaxel 10.0 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Teva B.V. Swensweg 5, Haarlem, 2031 GA, Netherlands
参考成员国 - 产品名称Austria (AT)
互认成员国 - 产品名称
    • Denmark (DK)
    • Netherlands (NL)
    • Hungary (HU)
      Cabazitaxel ratiopharm 10mg/ml koncentrátum oldatos infúzióhoz
    • Bulgaria (BG)
      Cabazitaxel Teva
    • Iceland (IS)
    • Czechia (CZ)
      Cabazitaxel Teva CR
    • Slovenia (SI)
    • France (FR)
    • Croatia (HR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Germany (DE)
    • Norway (NO)
许可日期2022/06/22
最近更新日期2024/04/18
药物ATC编码
    • L01CD04 cabazitaxel
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase